A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
作者信息
Staschak S, Wagner S, Block G, Van Thiel D H, Jain A, Fung J, Todo S, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, PA.
出版信息
Transplant Proc. 1990 Feb;22(1):47-9.
Abstract
摘要
相似文献
1
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
Transplant Proc. 1990 Feb;22(1):47-9.
2
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
Transplant Proc. 1991 Feb;23(1 Pt 1):396-9.
3
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
4
Transplantation's newest weapon FK 506.
Am J Nurs. 1991 Oct;91(10):40-2.
5
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA.
Transplant Proc. 1991 Feb;23(1 Pt 1):334-5.
6
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation.
Transplant Proc. 1990 Dec;22(6):2485-6.
7
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts.
Transplant Proc. 1991 Aug;23(4):2233-5.
8
Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine.
Transplant Proc. 1991 Feb;23(1 Pt 1):540-1.
9
Effect of FK 506 and cyclosporine on heart allograft survival in rats.
Transplant Proc. 1991 Feb;23(1 Pt 1):529-30.
10
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Transplant Proc. 1990 Feb;22(1):37-40.
引用本文的文献
1
Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
Pharmacoeconomics. 1998 Dec;14(6):691-708. doi: 10.2165/00019053-199814060-00009.
2
A cost analysis of alprostadil in liver transplantation.
Pharmacoeconomics. 1996 Jun;9(6):517-24. doi: 10.2165/00019053-199609060-00006.
3
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders.
J Clin Pharmacol. 1993 Jul;33(7):599-605. doi: 10.1002/j.1552-4604.1993.tb04711.x.
4
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Human liver transplantation: analysis of data on 540 patients from four centers.
Hepatology. 1984 Jan-Feb;4(1 Suppl):95S-101S. doi: 10.1002/hep.1840040723.
2
Medical treatment vs. transplantation in liver disorders.
Hepatology. 1984 Jan-Feb;4(1 Suppl):102S-106S. doi: 10.1002/hep.1840040724.
3
Liver transplantation.
Transplant Proc. 1987 Feb;19(1 Pt 1):103-12.
4
Liver transplantation today.
Ann Intern Med. 1986 Mar;104(3):377-89. doi: 10.7326/0003-4819-104-3-377.
5
Medical problems before and after transplantation.
Gastroenterol Clin North Am. 1988 Mar;17(1):19-31.
6
Liver transplantation: an overview.
Hepatology. 1988 Jul-Aug;8(4):948-59. doi: 10.1002/hep.1840080440.
7
Liver transplantation in adults. An analysis of costs and benefits at the University of Pittsburgh.
Gastroenterology. 1986 Jan;90(1):211-6.
8
Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy.
Ann Surg. 1989 May;209(5):513-25. doi: 10.1097/00000658-198905000-00002.
Zotero 插件